NXTC FY 2023 Earnings — NextCure, Inc. Revenue & Financial Results | Market Cap Arena

NXTCNextCure, Inc.

$36M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$68M

Net Income

-$63M

EPS (Diluted)

$-27.04

Cash Flow

Operating Cash Flow

-$53M

Free Cash Flow

-$54M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$128M

Total Liabilities

$14M

Stockholders' Equity

$114M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$68M	-$76M	+10.9%
Net Income	-$63M	-$75M	+16.1%